Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 31/12/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Research and development | 6M | 5M | 4M | 7M | 904,923 | 2M |
| Selling, general and administrative | 9M | 7M | 5M | 16M | 2M | 2M |
| Operating expenses | 14M | 12M | 9M | 22M | 4M | 5M |
| Net income | −9M | −7M | −8M | −21M | −3M | −5M |
| Earnings per share | −0.18 | −0.13 | −0.19 | −0.57 | −0.09 | −0.17 |
| Earnings per share, diluted | −0.18 | −0.13 | −0.19 | −0.57 | −0.09 | −0.17 |
| Weighted average shares | 52M | 50M | 39M | 37M | 34M | 28M |
| Weighted average shares, diluted | 52M | 50M | 39M | 37M | 34M | 28M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 198M | 578M | 203M | 210M | 119M | 123M | 29M | — |
| Short-term investments | 371M | 279,677 |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −4M | −3M |
| Depreciation and amortisation | 208,408 | 19,976 |
| Share-based compensation | 2M | — |
| Investing cash flow | −3M | −4M |
| Financing cash flow | 381M | 102M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| — |
| — |
| — |
| — |
| — |
| — |
| Receivables | — | — | 250,000 | — | — | — | — | — |
| Current assets | 572M | 581M | 205M | 212M | 119M | 128M | 29M | 14M |
| Property, plant and equipment | 18M | 11M | 10M | 5M | 5M | 2M | 2M | — |
| Total assets | 604M | 606M | 229M | 232M | 139M | 134M | 35M | 16M |
| Current liabilities | 6M | 4M | 4M | 3M | 4M | 3M | 2M | 2M |
| Total liabilities | 8M | 6M | 6M | 5M | 7M | 4M | 3M | 3M |
| Equity | 596M | 600M | 223M | 226M | 132M | 130M | 32M | 13M |
| Shares outstanding | 52M | 51M | 42M | 42M | 37M | 37M | 31M | 29M |
| Shares issued | 52M | 51M | 42M | 42M | 37M | 37M | 31M | 29M |